A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironmentsKevin C. Barry, Matthew F. Krummel, Joy Hsu et al.|Nature Medicine|2018Cited by 1k
Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)Conor Gruber, Dusan Bogunovic, Timothy J. O’Donnell et al.|Cell|2020Cited by 555
Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndromeMarije Meuwissen, Grazia M.S. Mancini, Rachel Schot et al.|The Journal of Experimental Medicine|2016Cited by 289
ISG15 deficiency and increased viral resistance in humans but not miceScott D. Speer, Dusan Bogunovic|Nature Communications|2016Cited by 198
Homozygous <i>STAT2</i> gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathyConor Gruber, Dusan Bogunovic|The Journal of Experimental Medicine|2020Cited by 117